viacoram 3,5 mg/2,5 mg comprimidos
les laboratoires servier - perindopril arginina; amlodipino besilato - comprimido - 3,5 mg/2,5 mg - perindopril arginina 3,5 mg; amlodipino besilato 2,5 mg - perindopril y amlodipino
viacoram 7 mg/5 mg comprimidos
les laboratoires servier - perindopril arginina; amlodipino besilato - comprimido - 7 mg/5 mg - perindopril arginina 7 mg; amlodipino besilato 5 mg - perindopril y amlodipino
cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - agentes antineoplásicos - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.
cometriq
ipsen pharma - cabozantinib - neoplasias tiroideas - agentes antineoplásicos - tratamiento de pacientes adultos con carcinoma de tiroides medular localmente avanzado o metastásico progresivo e irresecable.
ketoconazole hra
hra pharma rare diseases - ketoconazol - síndrome de cushing - antimicóticos para uso sistémico - ketoconazol hra está indicado para el tratamiento del síndrome de cushing endógeno en adultos y adolescentes mayores de 12 años..
viacorlix 7 mg/5 mg/2,5 mg comprimidos recubiertos con pelicula
les laboratoires servier - indapamida; amlodipino; perindopril arginina - comprimido recubierto con pelÍcula - 7 mg/5 mg/2,5 mg - indapamida 2,5 mg; amlodipino 5 mg; perindopril arginina 7 mg - perindopril, amlodipino e indapamida
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - carcinoma, pulmón no microcítico - agentes antineoplásicos - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
onglyza 5 mg comprimido recubierto
astrazeneca (distribución exclusiva por gramón bagó de uruguay s.a.) - comprimido recubierto - saxagliptina 5 mg comprimido
kombiglyze xr 5 mg/1000 mg comprimido recubierto de liberación prolongada
astrazeneca (distribución exclusiva por gramón bagó de uruguay s.a.) - comprimido recubierto de liberación prolongada - saxagliptina 5 mg + metformina 1 g comprimido de liberación modificada
arteoptic 1% colirio de liberacion prolongada
bausch + lomb ireland limited - carteolol hidrocloruro - colirio de liberacion prolongada - 10 mg/ml - carteolol hidrocloruro 10 mg - carteolol